The purification of proteins and antibodies is a critical process in biotechnology and pharmaceutical industries. Traditional methods often involve single-use materials, leading to high costs and ...

As therapeutic antibodies evolve, the industry is moving away from a one-size-fits-all chromatography approach. With an increasing share of non-traditional monoclonal antibodies (mAbs)—including ...

Efficient purification of plasmids, proteins, and antibodies is critical for drug target identification, drug candidate development, and fundamental research. However, traditional column-based methods ...

Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...

Antibody manufacturers should be encouraged to revisit older technologies as the industry moves towards continuous processing. That’s the view of Andrew Zydney, PhD, professor, chemical engineering, ...

Nuclera extended its Series C with $12M, bringing total to $87M, to expand Protein Discovery with full-format antibody ...

Focusing on the establishment of Sino Biological‘s Center for Bioprocessing (C4B) in Houston, it highlights how the ...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new research paper from its global research and development Center (R&D ...

Extracting therapeutic antibodies from biological systems requires stringent purification processes. To reduce costs and accelerate development, novel strategies are essential ...